Recombinant COVID-19 vaccine (Sf9 cells)

BIOLOGICAL3 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention, WestVac Biopharma Co., Ltd.

Conditions

COVID-19

Phase 1

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

WithdrawnNCT05013983

WestVac Biopharma Co., Ltd.COVID-19

Start: 2024-07-31End: 2025-12-31Updated: 2025-03-28

Phase 2

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

WithdrawnNCT04718467

Jiangsu Province Centers for Disease Control and PreventionCOVID-19

Start: 2021-02-01End: 2022-03-15Updated: 2021-05-25

Phase 3

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

CompletedNCT04904471

WestVac Biopharma Co., Ltd.COVID-19

Start: 2021-06-15End: 2023-11-01Updated: 2025-03-26